-
1
-
-
56449131391
-
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
-
Binley, J.M., E.A. Lybarger, E.T. Crooks, M.S. Seaman, E. Gray, K.L. Davis, J.M. Decker, D. Wycuff, L. Harris, N. Hawkins, et al. 2008. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J. Virol. 82:11651-11668. http://dx.doi.org/10.1128/JVI.01762-08
-
(2008)
J. Virol.
, vol.82
, pp. 11651-11668
-
-
Binley, J.M.1
Lybarger, E.A.2
Crooks, E.T.3
Seaman, M.S.4
Gray, E.5
Davis, K.L.6
Decker, J.M.7
Wycuff, D.8
Harris, L.9
Hawkins, N.10
-
2
-
-
82755184131
-
Increasing the potency and breadth of an HIV antibody by using structure-based rational design
-
Diskin, R., J.F. Scheid, P.M. Marcovecchio, A.P. West Jr., F. Klein, H. Gao, P.N. Gnanapragasam, A. Abadir, M.S. Seaman, M.C. Nussenzweig, and P.J. Bjorkman. 2011. Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science. 334:1289-1293. http://dx.doi.org/10.1126/science.1213782
-
(2011)
Science
, vol.334
, pp. 1289-1293
-
-
Diskin, R.1
Scheid, J.F.2
Marcovecchio, P.M.3
West Jr., A.P.4
Klein, F.5
Gao, H.6
Gnanapragasam, P.N.7
Abadir, A.8
Seaman, M.S.9
Nussenzweig, M.C.10
Bjorkman, P.J.11
-
3
-
-
79955389756
-
The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection
-
CAPRISA002 Study Team
-
Gray, E.S., M.C. Madiga, T. Hermanus, P.L. Moore, C.K. Wibmer, N.L. Tumba, L. Werner, K. Mlisana, S. Sibeko, C. Williamson, et al; CAPRISA002 Study Team. 2011a. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection. J. Virol. 85:4828-4840. http://dx.doi.org/10.1128/JVI.00198-11
-
(2011)
J. Virol.
, vol.85
, pp. 4828-4840
-
-
Gray, E.S.1
Madiga, M.C.2
Hermanus, T.3
Moore, P.L.4
Wibmer, C.K.5
Tumba, N.L.6
Werner, L.7
Mlisana, K.8
Sibeko, S.9
Williamson, C.10
-
4
-
-
79959301474
-
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
-
HVTN 503/Phambili study team
-
Gray, G.E., M. Allen, Z. Moodie, G. Churchyard, L.G. Bekker, M. Nchabeleng, K. Mlisana, B. Metch, G. de Bruyn, M.H. Latka, et al; HVTN 503/Phambili study team. 2011b. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect. Dis. 11:507-515. http://dx.doi.org/10.1016/S1473-3099(11)70098-6
-
(2011)
Lancet Infect. Dis.
, vol.11
, pp. 507-515
-
-
Gray, G.E.1
Allen, M.2
Moodie, Z.3
Churchyard, G.4
Bekker, L.G.5
Nchabeleng, M.6
Mlisana, K.7
Metch, B.8
de Bruyn, G.9
Latka, M.H.10
-
5
-
-
84875061923
-
Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs
-
Hoot, S., A.T. McGuire, K.W. Cohen, R.K. Strong, L. Hangartner, F. Klein, R. Diskin, J.F. Scheid, D.N. Sather, D.R. Burton, and L. Stamatatos. 2013. Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs. PLoS Pathog. 9:e1003106. http://dx.doi.org/10.1371/journal.ppat.1003106
-
(2013)
PLoS Pathog.
, vol.9
-
-
Hoot, S.1
McGuire, A.T.2
Cohen, K.W.3
Strong, R.K.4
Hangartner, L.5
Klein, F.6
Diskin, R.7
Scheid, J.F.8
Sather, D.N.9
Burton, D.R.10
Stamatatos, L.11
-
6
-
-
34247340435
-
Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors
-
Horikawa, K., S.W. Martin, S.L. Pogue, K. Silver, K. Peng, K. Takatsu, and C.C. Goodnow. 2007. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J. Exp. Med. 204:759-769. http://dx.doi.org/10.1084/jem.20061923
-
(2007)
J. Exp. Med.
, vol.204
, pp. 759-769
-
-
Horikawa, K.1
Martin, S.W.2
Pogue, S.L.3
Silver, K.4
Peng, K.5
Takatsu, K.6
Goodnow, C.C.7
-
7
-
-
80052334922
-
RosettaRemodel: a generalized framework for flexible backbone protein design
-
Huang, P.S., Y.E. Ban, F. Richter, I. Andre, R. Vernon, W.R. Schief, and D. Baker. 2011. RosettaRemodel: a generalized framework for flexible backbone protein design. PLoS ONE. 6:e24109. http://dx.doi.org/10.1371/journal.pone.0024109
-
(2011)
PLoS ONE.
, vol.6
-
-
Huang, P.S.1
Ban, Y.E.2
Richter, F.3
Andre, I.4
Vernon, R.5
Schief, W.R.6
Baker, D.7
-
8
-
-
84866495323
-
Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies
-
Kwong, P.D., and J.R. Mascola. 2012. Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. Immunity. 37:412-425. http://dx.doi.org/10.1016/j.immuni.2012.08.012
-
(2012)
Immunity.
, vol.37
, pp. 412-425
-
-
Kwong, P.D.1
Mascola, J.R.2
-
9
-
-
34948854718
-
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
-
Li, Y., S.A. Migueles, B. Welcher, K. Svehla, A. Phogat, M.K. Louder, X. Wu, G.M. Shaw, M. Connors, R.T. Wyatt, and J.R. Mascola. 2007. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat. Med. 13:1032-1034. http://dx.doi.org/10.1038/nm1624
-
(2007)
Nat. Med.
, vol.13
, pp. 1032-1034
-
-
Li, Y.1
Migueles, S.A.2
Welcher, B.3
Svehla, K.4
Phogat, A.5
Louder, M.K.6
Wu, X.7
Shaw, G.M.8
Connors, M.9
Wyatt, R.T.10
Mascola, J.R.11
-
10
-
-
80052287270
-
Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01
-
Li, Y., S. O'Dell, L.M. Walker, X. Wu, J. Guenaga, Y. Feng, S.D. Schmidt, K. McKee, M.K. Louder, J.E. Ledgerwood, et al. 2011. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. J. Virol. 85:8954-8967. http://dx.doi.org/10.1128/JVI.00754-11
-
(2011)
J. Virol.
, vol.85
, pp. 8954-8967
-
-
Li, Y.1
O'Dell, S.2
Walker, L.M.3
Wu, X.4
Guenaga, J.5
Feng, Y.6
Schmidt, S.D.7
McKee, K.8
Louder, M.K.9
Ledgerwood, J.E.10
-
11
-
-
0033942750
-
V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies
-
Ly, A., and L. Stamatatos. 2000. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. J. Virol. 74:6769-6776. http://dx.doi.org/10.1128/JVI.74.15.6769-6776.2000
-
(2000)
J. Virol.
, vol.74
, pp. 6769-6776
-
-
Ly, A.1
Stamatatos, L.2
-
12
-
-
84863769888
-
The development of CD4 binding site antibodies during HIV-1 infection
-
CHAVI 001 Clinical Team Members
-
Lynch, R.M., L. Tran, M.K. Louder, S.D. Schmidt, M. Cohen, R. Dersimonian, Z. Euler, E.S. Gray, S. Abdool Karim, J. Kirchherr, et al; CHAVI 001 Clinical Team Members. 2012. The development of CD4 binding site antibodies during HIV-1 infection. J. Virol. 86:7588-7595. http://dx.doi.org/10.1128/JVI.00734-12
-
(2012)
J. Virol.
, vol.86
, pp. 7588-7595
-
-
Lynch, R.M.1
Tran, L.2
Louder, M.K.3
Schmidt, S.D.4
Cohen, M.5
Dersimonian, R.6
Euler, Z.7
Gray, E.S.8
Abdool Karim, S.9
Kirchherr, J.10
-
13
-
-
77952311370
-
The role of antibodies in HIV vaccines
-
Mascola, J.R., and D.C. Montefiori. 2010. The role of antibodies in HIV vaccines. Annu. Rev. Immunol. 28:413-444. http://dx.doi.org/10.1146/annurev-immunol-030409-101256
-
(2010)
Annu. Rev. Immunol.
, vol.28
, pp. 413-444
-
-
Mascola, J.R.1
Montefiori, D.C.2
-
14
-
-
79551518897
-
Characteristics of the earliest cross-neutralizing antibody response to HIV-1
-
Mikell, I., D.N. Sather, S.A. Kalams, M. Altfeld, G. Alter, and L. Stamatatos. 2011. Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog. 7:e1001251. http://dx.doi.org/10.1371/journal.ppat.1001251
-
(2011)
PLoS Pathog.
, vol.7
-
-
Mikell, I.1
Sather, D.N.2
Kalams, S.A.3
Altfeld, M.4
Alter, G.5
Stamatatos, L.6
-
15
-
-
84868597004
-
Anti-HIV B Cell lines as candidate vaccine biosensors
-
Ota, T., C. Doyle-Cooper, A.B. Cooper, M. Huber, E. Falkowska, K.J. Doores, L. Hangartner, K. Le, D. Sok, J. Jardine, et al. 2012. Anti-HIV B Cell lines as candidate vaccine biosensors. J. Immunol. 189:4816-4824. http://dx.doi.org/10.4049/jimmunol.1202165
-
(2012)
J. Immunol.
, vol.189
, pp. 4816-4824
-
-
Ota, T.1
Doyle-Cooper, C.2
Cooper, A.B.3
Huber, M.4
Falkowska, E.5
Doores, K.J.6
Hangartner, L.7
Le, K.8
Sok, D.9
Jardine, J.10
-
16
-
-
58149487645
-
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection
-
Sather, D.N., J. Armann, L.K. Ching, A. Mavrantoni, G. Sellhorn, Z. Caldwell, X. Yu, B. Wood, S. Self, S. Kalams, and L. Stamatatos. 2009. Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J. Virol. 83:757-769. http://dx.doi.org/10.1128/JVI.02036-08
-
(2009)
J. Virol.
, vol.83
, pp. 757-769
-
-
Sather, D.N.1
Armann, J.2
Ching, L.K.3
Mavrantoni, A.4
Sellhorn, G.5
Caldwell, Z.6
Yu, X.7
Wood, B.8
Self, S.9
Kalams, S.10
Stamatatos, L.11
-
17
-
-
21644446614
-
The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner
-
Saunders, C.J., R.A. McCaffrey, I. Zharkikh, Z. Kraft, S.E. Malenbaum, B. Burke, C. Cheng-Mayer, and L. Stamatatos. 2005. The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. J. Virol. 79:9069-9080. http://dx.doi.org/10.1128/JVI.79.14.9069-9080.2005
-
(2005)
J. Virol.
, vol.79
, pp. 9069-9080
-
-
Saunders, C.J.1
McCaffrey, R.A.2
Zharkikh, I.3
Kraft, Z.4
Malenbaum, S.E.5
Burke, B.6
Cheng-Mayer, C.7
Stamatatos, L.8
-
18
-
-
80052925616
-
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding
-
Scheid, J.F., H. Mouquet, B. Ueberheide, R. Diskin, F. Klein, T.Y. Oliveira, J. Pietzsch, D. Fenyo, A. Abadir, K. Velinzon, et al. 2011. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science. 333:1633-1637. http://dx.doi.org/10.1126/science.1207227
-
(2011)
Science
, vol.333
, pp. 1633-1637
-
-
Scheid, J.F.1
Mouquet, H.2
Ueberheide, B.3
Diskin, R.4
Klein, F.5
Oliveira, T.Y.6
Pietzsch, J.7
Fenyo, D.8
Abadir, A.9
Velinzon, K.10
-
19
-
-
69549091674
-
Challenges for structurebased HIV vaccine design
-
Schief, W.R., Y.E. Ban, and L. Stamatatos. 2009. Challenges for structurebased HIV vaccine design. Curr Opin HIV AIDS. 4:431-440. http://dx.doi.org/10.1097/COH.0b013e32832e6184
-
(2009)
Curr Opin HIV AIDS.
, vol.4
, pp. 431-440
-
-
Schief, W.R.1
Ban, Y.E.2
Stamatatos, L.3
-
20
-
-
70649096029
-
Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection
-
Sellhorn, G., Z. Caldwell, C. Mineart, and L. Stamatatos. 2009. Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection. Vaccine. 28:430-436. http://dx.doi.org/10.1016/j.vaccine.2009.10.028
-
(2009)
Vaccine.
, vol.28
, pp. 430-436
-
-
Sellhorn, G.1
Caldwell, Z.2
Mineart, C.3
Stamatatos, L.4
-
21
-
-
84862641275
-
HIV vaccine design: the neutralizing antibody conundrum
-
Stamatatos, L. 2012. HIV vaccine design: the neutralizing antibody conundrum. Curr. Opin. Immunol. 24:316-323. http://dx.doi.org/10.1016/j.coi.2012.04.006
-
(2012)
Curr. Opin. Immunol.
, vol.24
, pp. 316-323
-
-
Stamatatos, L.1
-
22
-
-
34247392757
-
IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta
-
Waisman, A., M. Kraus, J. Seagal, S. Ghosh, D. Melamed, J. Song, Y. Sasaki, S. Classen, C. Lutz, F. Brombacher, et al. 2007. IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J. Exp. Med. 204:747-758. http://dx.doi.org/10.1084/jem.20062024
-
(2007)
J. Exp. Med.
, vol.204
, pp. 747-758
-
-
Waisman, A.1
Kraus, M.2
Seagal, J.3
Ghosh, S.4
Melamed, D.5
Song, J.6
Sasaki, Y.7
Classen, S.8
Lutz, C.9
Brombacher, F.10
-
23
-
-
0037147182
-
A distinct signaling pathway used by the IgG-containing B cell antigen receptor
-
Wakabayashi, C., T. Adachi, J. Wienands, and T. Tsubata. 2002. A distinct signaling pathway used by the IgG-containing B cell antigen receptor. Science. 298:2392-2395. http://dx.doi.org/10.1126/science.1076963
-
(2002)
Science
, vol.298
, pp. 2392-2395
-
-
Wakabayashi, C.1
Adachi, T.2
Wienands, J.3
Tsubata, T.4
-
24
-
-
84864363185
-
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
-
West, A.P. Jr., R. Diskin, M.C. Nussenzweig, and P.J. Bjorkman. 2012. Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120. Proc. Natl. Acad. Sci. USA. 109:E2083-E2090. http://dx.doi.org/10.1073/pnas.1208984109
-
(2012)
Proc. Natl. Acad. Sci. USA.
, vol.109
-
-
West Jr., A.P.1
Diskin, R.2
Nussenzweig, M.C.3
Bjorkman, P.J.4
-
25
-
-
77954920017
-
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
-
Wu, X., Z.Y. Yang, Y. Li, C.M. Hogerkorp, W.R. Schief, M.S. Seaman, T. Zhou, S.D. Schmidt, L. Wu, L. Xu, et al. 2010. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science. 329:856-861. http://dx.doi.org/10.1126/science.1187659
-
(2010)
Science.
, vol.329
, pp. 856-861
-
-
Wu, X.1
Yang, Z.Y.2
Li, Y.3
Hogerkorp, C.M.4
Schief, W.R.5
Seaman, M.S.6
Zhou, T.7
Schmidt, S.D.8
Wu, L.9
Xu, L.10
-
26
-
-
80052942203
-
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing
-
NISC Comparative Sequencing Program
-
Wu, X., T. Zhou, J. Zhu, B. Zhang, I. Georgiev, C. Wang, X. Chen, N.S. Longo, M. Louder, K. McKee, et al; NISC Comparative Sequencing Program. 2011. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science. 333:1593-1602. http://dx.doi.org/10.1126/science.1207532
-
(2011)
Science.
, vol.333
, pp. 1593-1602
-
-
Wu, X.1
Zhou, T.2
Zhu, J.3
Zhang, B.4
Georgiev, I.5
Wang, C.6
Chen, X.7
Longo, N.S.8
Louder, M.9
McKee, K.10
-
27
-
-
0027194743
-
Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions
-
Wyatt, R., N. Sullivan, M. Thali, H. Repke, D. Ho, J. Robinson, M. Posner, and J. Sodroski. 1993. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67:4557-4565.
-
(1993)
J. Virol.
, vol.67
, pp. 4557-4565
-
-
Wyatt, R.1
Sullivan, N.2
Thali, M.3
Repke, H.4
Ho, D.5
Robinson, J.6
Posner, M.7
Sodroski, J.8
-
28
-
-
70449701456
-
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens
-
Xiao, X., W. Chen, Y. Feng, Z. Zhu, P. Prabakaran, Y. Wang, M.Y. Zhang, N.S. Longo, and D.S. Dimitrov. 2009. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. Biochem. Biophys. Res. Commun. 390: 404-409. http://dx.doi.org/10.1016/j.bbrc.2009.09.029
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.390
, pp. 404-409
-
-
Xiao, X.1
Chen, W.2
Feng, Y.3
Zhu, Z.4
Prabakaran, P.5
Wang, Y.6
Zhang, M.Y.7
Longo, N.S.8
Dimitrov, D.S.9
-
29
-
-
77954943648
-
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01
-
Zhou, T., I. Georgiev, X. Wu, Z.Y. Yang, K. Dai, A. Finzi, Y.D. Kwon, J.F. Scheid, W. Shi, L. Xu, et al. 2010. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science. 329:811-817. http://dx.doi.org/10.1126/science.1192819
-
(2010)
Science.
, vol.329
, pp. 811-817
-
-
Zhou, T.1
Georgiev, I.2
Wu, X.3
Yang, Z.Y.4
Dai, K.5
Finzi, A.6
Kwon, Y.D.7
Scheid, J.F.8
Shi, W.9
Xu, L.10
|